- Home
- OXSQ vs INBX Comparison
OXSQ vs INBX Comparison
Compare OXSQ & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXSQ
- INBX
- Stock Information
- Founded
- OXSQ 2003
- INBX 2010
- Country
- OXSQ United States
- INBX United States
- Employees
- OXSQ N/A
- INBX N/A
- Industry
- OXSQ Blank Checks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- OXSQ Finance
- INBX Health Care
- Exchange
- OXSQ Nasdaq
- INBX Nasdaq
- Market Cap
- OXSQ 164.9M
- INBX 178.5M
- IPO Year
- OXSQ N/A
- INBX 2020
- Fundamental
- Price
- OXSQ $2.28
- INBX $21.73
- Analyst Decision
- OXSQ
- INBX Hold
- Analyst Count
- OXSQ 0
- INBX 1
- Target Price
- OXSQ N/A
- INBX N/A
- AVG Volume (30 Days)
- OXSQ 614.2K
- INBX 120.3K
- Earning Date
- OXSQ 08-12-2025
- INBX 08-12-2025
- Dividend Yield
- OXSQ 18.38%
- INBX N/A
- EPS Growth
- OXSQ N/A
- INBX N/A
- EPS
- OXSQ N/A
- INBX 111.58
- Revenue
- OXSQ $42,166,831.00
- INBX $200,000.00
- Revenue This Year
- OXSQ N/A
- INBX N/A
- Revenue Next Year
- OXSQ N/A
- INBX N/A
- P/E Ratio
- OXSQ N/A
- INBX $0.20
- Revenue Growth
- OXSQ N/A
- INBX N/A
- 52 Week Low
- OXSQ $2.14
- INBX $10.80
- 52 Week High
- OXSQ $3.10
- INBX $22.28
- Technical
- Relative Strength Index (RSI)
- OXSQ 49.98
- INBX 84.22
- Support Level
- OXSQ $2.14
- INBX $13.97
- Resistance Level
- OXSQ $2.32
- INBX $15.25
- Average True Range (ATR)
- OXSQ 0.03
- INBX 1.10
- MACD
- OXSQ 0.01
- INBX 0.66
- Stochastic Oscillator
- OXSQ 77.78
- INBX 95.32
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.